104 related articles for article (PubMed ID: 18606965)
1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
[TBL] [Abstract][Full Text] [Related]
2. Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.
Khoury CK; Couch JR
Drug Des Devel Ther; 2010 Feb; 4():9-17. PubMed ID: 20368903
[TBL] [Abstract][Full Text] [Related]
3. Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study.
Krymchantowski AV; Peixoto P; Higashi R; Silva A; Schutz V
MedGenMed; 2005 Dec; 7(4):69. PubMed ID: 16614691
[TBL] [Abstract][Full Text] [Related]
4. Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan.
Newman LC; Cady RK; Landy S; O'Carroll P; Kwong WJ; Burch SP; Nelsen AC; McDonald SA
Int J Clin Pract; 2008 Dec; 62(12):1889-99. PubMed ID: 19166436
[TBL] [Abstract][Full Text] [Related]
5. Modulation of brain networks by sumatriptan-naproxen in the inflammatory soup migraine model.
Bishop J; Becerra L; Barmettler G; Chang PC; Kainz V; Burstein R; Borsook D
Pain; 2019 Sep; 160(9):2161-2171. PubMed ID: 31033778
[TBL] [Abstract][Full Text] [Related]
6. Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.
Peterlin BL; Tietjen GE; Gower BA; Ward TN; Tepper SJ; White LW; Dash PD; Hammond ER; Haythornthwaite JA
Headache; 2013 Mar; 53(3):474-90. PubMed ID: 23489216
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of dietary factors in the management and prophylaxis of migraine.
Zencirci B
J Pain Res; 2010 Jul; 3():125-30. PubMed ID: 21197315
[TBL] [Abstract][Full Text] [Related]
8. Migraine: from pathophysiology to treatment.
Puledda F; Silva EM; Suwanlaong K; Goadsby PJ
J Neurol; 2023 Jul; 270(7):3654-3666. PubMed ID: 37029836
[TBL] [Abstract][Full Text] [Related]
9. Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.
Kouremenos E; Arvaniti C; Constantinidis TS; Giannouli E; Fakas N; Kalamatas T; Kararizou E; Naoumis D; Mitsikostas DD;
J Headache Pain; 2019 Dec; 20(1):113. PubMed ID: 31835997
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
[TBL] [Abstract][Full Text] [Related]
11. Sumatriptan/Naproxen Sodium: A Review in Migraine.
Syed YY
Drugs; 2016 Jan; 76(1):111-21. PubMed ID: 26628293
[TBL] [Abstract][Full Text] [Related]
12. Sumatriptan/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes study.
Landy S; Hoagland R; Hoagland D; Saiers J; Reuss G
Ther Adv Neurol Disord; 2013 Sep; 6(5):279-86. PubMed ID: 23997813
[TBL] [Abstract][Full Text] [Related]
13. Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.
Yang LP
Drugs; 2013 Aug; 73(12):1339-55. PubMed ID: 23912627
[TBL] [Abstract][Full Text] [Related]
14. Taking the negative view of current migraine treatments: the unmet needs.
Tfelt-Hansen P; Olesen J
CNS Drugs; 2012 May; 26(5):375-82. PubMed ID: 22519921
[TBL] [Abstract][Full Text] [Related]
15. Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.
Vause CV; Durham PL
Headache; 2012 Jan; 52(1):80-9. PubMed ID: 22150557
[TBL] [Abstract][Full Text] [Related]
16. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders.
Krymchantowski AV; da Cunha Jevoux C; Bigal ME
J Headache Pain; 2012 Jan; 13(1):53-9. PubMed ID: 22008899
[TBL] [Abstract][Full Text] [Related]
17. Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse Events.
Landy S; White J; Lener SE; McDonald SA
Ther Adv Neurol Disord; 2009 May; 2(3):135-41. PubMed ID: 21179523
[TBL] [Abstract][Full Text] [Related]
18. Are the current IHS guidelines for migraine drug trials being followed?
Hougaard A; Tfelt-Hansen P
J Headache Pain; 2010 Dec; 11(6):457-68. PubMed ID: 20931348
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
